Medical Device News Magazine

Matthew Cranfill New ExtriCARE USA Director Of Clinical Services

Industry Veteran Matthew Cranfill, RN, BSN, WOCN, Will Lead the Company's NPWT Clinical Support & Education.

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Matthew Cranfill, RN, BSN, WOCN, has been named as Director of Clinical Services reports ExtriCare USA today.

Matthew Cranfill will oversee ExtriCARE USA’s clinical services, focusing on product development and wound care education. With over 23 years of clinical experience and a distinguished track record in wound healing, Cranfill will take ExtriCARE USA’s clinical program to the next level.

“Matt’s impressive experience and skillset easily made him our top pick,” said Peter Mason, President of ExtriCARE USA. “His eagerness to innovate and hands-on approach deeply aligns with our company vision. Matt brings tremendous value to our expanding team, and I’m excited about the impact he will have on our future growth.”

Combining his extensive background and passion for wound healing, Cranfill brings the dedication and leadership necessary to drive ExtriCARE USA’s clinical services. He has a keen eye for figuring out how to improve patient outcomes and clinician satisfaction.

“I’m thrilled to be joining ExtriCARE USA’s forward-thinking team at such a pivotal time in wound care,” said Cranfill. “There’s a lot of potential for growth and innovation in the NPWT market, and I look forward to applying my clinical perspective to enhance the outcomes for the clients, clinicians and patients who use our products.”

ExtriCARE USA firmly believes in NPWT’s potential and is proactively investing in its future. The company is cultivating a strong network of dealers who will have direct clinical support and educational resources. ExtriCARE USA’s goal is to boost the growth and success of NPWT, optimizing clinician satisfaction and the patient healing experience.

Looking ahead, ExtriCARE USA will be launching new portable, powerful and adaptive NPWT solutions to the market.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”